|
|
||||||||
Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky 40536
| |
ABSTRACT |
|---|
|
|
|---|
With the use of markers of sarcolemmal membrane permeability, cardiomyocyte models of ischemic injury have primarily addressed necrotic death during ischemia. In the present study, we used annexin V-propidium iodide staining to examine apoptosis and necrosis after simulated ischemia and simulated reperfusion in rat ventricular myocytes. Annexin V binds phosphatidylserine, a phosphoaminolipid thought to be externalized during apoptosis or programmed cell death. Propidium iodide is a marker of cell necrosis. Under baseline conditions, <1% of cardiomyocytes stained positive for annexin V. After 20 or 60 min of simulated ischemia, there was no increase in annexin V staining, although 60-min simulated ischemia resulted in significant propidium iodide staining. Twenty minutes of simulated ischemia, followed by 20 or 60 min of simulated reperfusion, resulted in 8-10% of myocytes staining positive for annexin V. Annexin V-positive cells retained both rod-shaped morphology and contractile function but exhibited the decreased cell width indicative of cell shrinkage. Baseline mitochondrial free Ca2+ (111 ± 14 nM) was elevated in reperfused annexin V-negative cells (214 ± 22 nM), and further elevated in annexin V-positive myocytes (382 ± 9 nM). After 60 min of simulated reperfusion, caspase-3-like activity was observed in ~3% of myocytes, which had a rounded appearance and membrane blebs. These results suggest that the use of annexin V after simulated ischemia-reperfusion uncovers a population of cardiomyocytes whose characteristics appear to be consistent with cells undergoing apoptosis.
rat heart; ischemia-reperfusion; mitochondrial calcium
| |
INTRODUCTION |
|---|
|
|
|---|
ISOLATED CARDIOMYOCYTE MODELS of simulated ischemia (SIsc) have lent much insight into the pathophysiology of myocardial ischemic injury. Free from neurohumoral influences and potentially confounding contributions from nonmyocyte cell types, these models have contributed to our understanding of both the ionic dyshomeostasis and the altered signal transduction accompanying ischemia (1, 7). In these studies (1, 7, 14), manipulations to protect the ischemic heart have largely focused on reducing necrotic cell death, which has typically been assessed by using indicators of sarcolemmal membrane permeability, such as trypan blue and enzyme release.
Results from several studies (6, 8, 21), however, indicate that reperfusion after myocardial ischemia can result in exacerbation of injury and apoptosis (programmed cell death). In fact, several studies (6, 8, 13, 21, 35) suggest that apoptosis is a reperfusion-related phenomenon. Because of reports (25, 34) indicating evidence of apoptosis in the peri-infarct and remote nonischemic zones of infarcted human myocardium, the mechanisms governing this death program have come under intense investigation. The majority of studies (5, 8, 21) examining myocardial reperfusion-related apoptosis have used techniques such as DNA fragmentation and evidence of DNA laddering. However, these techniques detect apoptosis at a very late stage, and cardiomyocytes with fragmented DNA have been reported (10, 17) to exhibit extensive membrane blebbing, mitochondrial and nuclear margination, and a condensed or rounded morphology. In contrast, data from numerous cell types have indicated that one of the earliest events in the apoptotic cascade is externalization of the phosphoaminolipid phosphatidylserine from the inner face of the plasma membrane to the outer cell surface (33). Fluorophore-labeled annexin V (a protein that exhibits nanomolar affinity for phosphatidylserine) binding to externalized phosphatidylserine has been extensively employed as a reliable marker of apoptosis (3, 13, 27).
If apoptosis is a physiologically relevant aspect of reperfusion injury and is truly unique from necrosis, as suggested by several noncardiac studies (20), then merely measuring cell death during ischemia based on membrane permeability may underestimate the extent of myocyte death during ischemia-reperfusion. In the present study, we examined the effects of SIsc and simulated reperfusion (SRP) in isolated rat ventricular myocytes by using annexin V-propidium iodide, markers of apoptosis and necrosis, respectively, morphology, mitochondrial free calcium concentration ([Ca2+]m), and twitch amplitude.
| |
METHODS |
|---|
|
|
|---|
Isolation of ventricular myocytes. Ventricular myocytes were enzymatically dissociated from male Sprague-Dawley rats (350-400 g) as previously described (24). Cardiomyocytes were suspended in standard HEPES buffer composed of (in mM) 130 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 10 HEPES, and 11 glucose (containing 200 µM CaCl2 at a pH of 7.4). This procedure routinely yielded >70% rod-shaped myocytes. For the experimental protocols, the same buffer with 1 mM CaCl2 was used. All data were collected within 6 h of myocyte isolation.
Myocyte imaging and analysis system. To visualize and quantify annexin V-propidium iodide staining, measurement of [Ca2+]m, and cardiomyocyte length, width, and twitch amplitude, we used an inverted microscope (model IX70, Olympus America; Melville, NY) equipped with a 75-W xenon arc lamp. Excitation and emission wavelengths were selected with the use of a variety of filter combinations. For functional measurements, cardiomyocytes were placed in a 0.3-ml recording chamber (Warner Instruments; Warrendale, PA), the floor of which was a 22 mm × 22 mm glass coverslip coated with laminin to enhance cell adherence. Both epifluorescence and the cardiomyocyte image (×200 magnification) were collected by the use of a charge-coupled device camera that was attached to a side port of the microscope. Image analysis was done with the use of a Pentium-based computer and custom-made software (Coyote Bay; Manchester, NH).
Annexin V-propidium iodide staining in cardiomyocytes.
Myocytes were stained with fluorescein isothiocyanate (FITC), annexin
V, and propidium iodide, as per the manufacturer's directions (Vybrant
Apoptosis Assay Kit 2, Molecular Probes) and visualized under a
fluorescence microscope. Cells were counted regardless of morphology.
Cells not binding FITC-annexin V and excluding propidium iodide were
classified as annexin V-negative (AN
ve) (26). Myocytes
that bound FITC-annexin V [excitation wavelength (
ex) = 488 nm and emission wavelength
(
em) = 520 nm] but excluded propidium iodide
(
ex = 540 nm and
em = 630 nm)
were termed annexin V-positive (AN+ve) and myocytes permeant to
propidium iodide (regardless of whether or not they bound FITC-annexin
V) were deemed necrotic (31).
Assay for caspase-3-like activity.
The protease caspase 3 is a cysteine protease that cleaves substrates
with a Asp-Glu-Val-Asp (DEVD) motif at the terminal aspartate
(30). Myocytes were incubated with the FITC-conjugated cell permeant aminopeptide, GDEVDGI, and propidium iodide as per manufacturer's directions (OncoImmunin; Gaithersburg, MD). Uncleaved GDEVDGI is not fluorescent, but after cleavage by caspase-3-like proteases, the cleaved fractions fluoresce (
ex = 488 nm and
em = 520 nm).
Measurement of [Ca2+]m: use of rhod 2 and Mn2+ quenching.
Myocytes were loaded with rhod 2-acetoxymethyl ester (10 µM;
Molecular Probes; Eugene, OR) for 20 min, followed by washout of the
dye. Aliquots of the rhod-2-labeled cell suspension were placed in the
temperature-controlled recording chamber and suffused with HEPES buffer
containing MnCl2 (100 µM, 20 min). Because some of the
deesterified rhod 2 is distributed in the cytosolic compartment, it is
necessary to eliminate the cytosolic component of the Ca2+
signal (23). Mn2+, which binds rhod 2 with
greater affinity than Ca2+, quenches the cytosolic
Ca2+ signal but does not enter mitochondrial compartment
(at least over 120 min) (23). After 20-min exposure to
MnCl2, suffusion with standard HEPES buffer was resumed and
fluorescence measurements (
ex = 540 nm and
em = 580 nm) were made. Conversion of the
fluorescence signal to [Ca2+] was done by the method of
Delcamp et al. (4). [Ca2+]m
(expressed in nM) was calculated using the equation
|
Measurement of cell length, cell width, and twitch amplitude. Maximal cell length parallel to the longitudinal axis (cardiomyocyte length) and maximal cell width perpendicular to the longitudinal axis (cardiomyocyte width) was measured using a micrometer grid. Amplitude of cell shortening (in response to electrical stimulation at 0.5 Hz, 37°C), expressed as a percentage of diastolic cell length, was computed as described previously by our laboratory (24).
SIsc and SRP protocol. After a 60-min postisolation equilibration period, aliquots of cell suspensions were placed in 1.5-ml Eppendorff tubes and pelleted at 100 g for 10 s, resulting in a pellet occupying a volume of ~100 µl. Excess supernatant was removed, leaving a thin fluid layer above the pellet. Mineral oil (200 µl) was then layered on top of the pellet to limit gaseous diffusion, and the Eppendorff tubes were placed in a nonshaking water bath at 37°C to simulate normothermic ischemia. At the end of ischemia, the mineral oil was aspirated and the cardiomyocytes resuspended either in phosphate-buffered saline or in standard HEPES buffer (gassed with 100% O2, 37°C).
Myocytes were submitted to either: 1) 20- or 60-min SIsc alone or 2) 20-min SIsc + 20- or 60-min SRP. To assess cardiomyocyte injury during SIsc, myocytes were resuspended in phosphate-buffered saline and stained with the annexin V-propidium iodide. To assess cardiomyocyte injury during SRP, myocytes were resuspended in oxygenated HEPES buffer and stained with the dyes. In certain experiments, SRP conditions were modified by the omission of either Ca2+ or O2 from the HEPES buffer. The latter was accomplished by gassing the buffer with 100% N2 (resulting in a PO2 of ~30 mmHg). Cardiomyocytes suspended under normoxic conditions served as time controls. Finally, to determine the effects of a reactive oxygen species (ROS) generating system on cell injury, a separate aliquot of myocytes (nonischemic) was exposed to 200 µM H2O2 for 20 min. After resuspension in standard HEPES buffer, cells were stained with FITC-annexin V-propidium iodide.Data analysis.
For quantification of AN
ve, AN+ve, and necrotic cells, ~300
cardiomyocytes were counted per heart per group and expressed as a
percentage of all cardiomyocytes counted. Data are expressed as
means ± SE. Within-group differences were determined by one-way analysis of variance (ANOVA), followed by Newman-Keuls post hoc analysis. A P value <0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Under baseline (nonischemic) conditions, the percentage of
AN
ve, AN+ve, and necrotic cardiomyocytes, as determined by
FITC-annexin V-propidium iodide staining, was 77.0 ± 1.5, 0.8 ± 0.2, and 22.0 ± 1.7, respectively (n = 12 hearts). Myocytes suspended under normoxic conditions retained
baseline viability over the 4- to 5-h experimental period. Twenty or
sixty minutes of SIsc alone did not result in an increase in AN + ve cells (~0.9% in each group, n = 5 hearts/group).
Twenty minutes of SIsc did not result in additional necrosis from
baseline (24.0 ± 2.1%), but sixty minutes of SIsc was associated
with significant cardiomyocyte necrosis (47.7 ± 3.0%,
P < 0.05 vs. baseline).
Figure 1, A-C, show
the effects of 20 min of SIsc and 20 min of SRP on cardiomyocytes. As
seen in Fig. 1A, under normal lighting conditions, there are
two rod-shaped myocytes and one rounded myocyte. Only the rounded
myocyte was permeable to propidium iodide indicating necrosis (Fig.
1B). As shown in Fig. 1C, of the two apparently
normal, rod-shaped cardiomyocytes, one fluoresced green due to
FITC-annexin V binding and was therefore classified as AN+ve.
|
Effects of 20-min SIsc, followed by 20- or 60-min SRP on the percentage
of cardiomyocytes staining positive for annexin V are shown in Fig.
2. Compared with baseline, 20 min SRP was
associated with an ~12-fold increase in AN+ve cells. Extending
reperfusion time from 20 to 60 min did not result in a significant
increase in this value. The percentages of necrotic cells at 20 and 60 min SRP were 28.4 ± 2.2 and 34.0 ± 3.0, respectively (both
values, P < 0.05 vs. baseline). When myocytes
(n = 3 hearts) were reperfused (20 min) in the absence
of extracellular Ca2+, the percentage of AN+ve cells was
1.5 ± 0.3, a value significantly lower compared with myocytes
reperfused in the presence of extracellular Ca2+ (7.5 ± 1.5%). In myocytes (n = 3 hearts) subjected to
20-min SIsc and reperfused (20 min) with buffer saturated with 100%
N2, 4.1 ± 0.5% of cells stained AN+ve
(P < 0.05 vs. control HEPES reperfusion). Finally,
exposure of normoxic cardiomyocytes to H2O2 (n = 3 hearts) resulted in
14.6 ± 2.1% AN+ve cells.
|
Although AN+ve cardiomyocytes exhibited rod-shaped morphology (Fig.
1C), closer examination revealed that these cells exhibited decreased cell width. Figure
3A shows cell length and width
in baseline (nonischemic), reperfused AN
ve and AN+ve
cardiomyocytes (n = 35 cells / group). Whereas cell
length was not different between groups, cell width in the AN+ve cells
was about one-half that of the AN
ve myocytes. Consequently, cell
length-to-width ratio was 6.8 ± 0.4 in AN+ve cardiomyocytes,
twice the ratio (3.4 ± 0.1) observed in AN
ve cells (Fig.
3B). Despite significantly different cell length-to-width
ratio, the twitch amplitude in both groups (n = 15 cells/group) was comparable (AN
ve, 5.3 ± 0.4%; AN+ve, 4.5 ± 0.5%) but considerably less than that observed in cardiomyocytes
subjected to normoxic, normothermic incubation (9.3 ± 1.0%).
|
It has been reported (23) that although cytosolic free
Ca2+ levels may be normal in reperfused rod-shaped
myocytes, [Ca2+]m is elevated. Because
increased [Ca2+]m is thought to play a role
in initiating apoptosis (28), we measured
[Ca2+]m in nonischemic and reperfused
myocytes. As shown in Fig. 4, nonischemic cells exhibited a baseline
[Ca2+]m of 111 ± 14 nM. After SRP,
[Ca2+]m in AN
ve cells was 214 ± 22 nM
and further elevated in AN+ve myocytes 382 ± 9 nM.
|
Activation of the executioner enzyme caspase 3 is a hallmark feature of the apoptotic cascade (5, 17, 30) and caspase-3-like activity was examined in cardiomyocytes subjected to 20 SIsc, followed by 20- or 60-min SRP. Caspase-3-like activity appeared in 0.03 ± 0.02% cells after 20-min SRP and in 2.85 ± 0.30% of cardiomyocytes after 60-min SRP. Myocytes staining positive for caspase 3 exhibited membrane blebs and a rounded morphology.
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, rat ventricular myocytes subjected to brief SIsc and SRP, but not SIsc alone, exhibited a significant increase in annexin V staining. Rod-shaped myocytes staining positive for annexin V excluded propidium iodide, indicating maintenance of sarcolemmal integrity. However, these same cells exhibited significantly decreased cell width and increased [Ca2+]m levels. During SRP, caspase-3-like activity was observed in cells with a rounded morphology and membrane blebbing. These results suggest that use of annexin V in the setting of SIsc-SRP uncovers a population of cardiomyocytes whose characteristics appear to be consistent with cells undergoing apoptosis.
The use of isolated adult mammalian cardiomyocyte models of SIsc-SRP can serve to distinguish between events occurring during ischemia versus those resulting from reperfusion and also provide a controlled environment for studying mechanisms underlying ischemia-reperfusion injury. However, the majority of single-cell studies (1, 7, 14) have typically addressed necrotic death during ischemia using markers of membrane permeability such as trypan blue staining and enzyme release. Although reperfusion can be associated with cardiomyocyte apoptosis (8, 21, 35), there have been few, if any, studies examining the deleterious effects of reperfusion (12). In fact, unlike necrosis, which occurs during ischemia-reperfusion, the majority of studies (6, 8, 21) suggest that myocardial apoptosis is a reperfusion-related phenomenon.
In the present study, necrotic cell death was assessed with propidium iodide, which stains the nuclei of cells with permeant membranes (15, 30). Our data indicated that only the long (60 min) simulated ischemic interval was associated with significant cardiomyocyte necrosis. On the other hand, SRP (but not SIsc alone) was associated with significant annexin V binding in cells excluding propidium iodide. Annexin V, a protein originally isolated from human placenta, but since found in other tissue, binds phosphatidylserine, a phosphoaminolipid that is externalized onto the outer surface of the plasma membrane during apoptosis or programmed cell death (33). When myocytes were reperfused with HEPES buffer lacking Ca2+ or saturated with N2 (PO2 ~30 mmHg), annexin V staining was significantly reduced. The exposure of nonischemic cardiomyocytes to the ROS generator H2O2 also resulted in a significant increase in annexin V-positive cells. These observations are consistent with the hypothesis that apoptosis occurs primarily during reperfusion (6, 8, 21) and is associated with intracellular oxidative stress and altered Ca2+ handling (15, 35, 29).
In addition to excluding propidium iodide, which is indicative of a
noncompromised sarcolemmal membrane, AN+ve cells also maintained
rod-shaped morphology. Hypoxia-reoxygenation studies (9,
12) in isolated cardiomyocytes have indicated that retention of
rod-shaped morphology is critically dependent on maintenance of
intracellular ATP levels. Thus our data suggested the presence of some
intracellular ATP in AN+ve cells. Despite the appearance of rod-shaped
morphology, detailed examination of annexin V myocytes revealed that
these cells exhibited decreased cell width, indicative of cell
shrinkage. This is in contrast to reperfused AN
ve cells, which
exhibited the increased cell width indicative of cell swelling. Measurement of unloaded shortening after sRP was not different between
AN+ve and AN
ve myocytes, although shortening was reduced compared
with nonischemic cells.
It has been reported (23) that while cytosolic free
Ca2+ levels may be normal in reperfused rod-shaped
myocytes, [Ca2+]m is elevated. Furthermore,
myocardial reperfusion injury has been intimately linked to
[Ca2+]m overload (22, 23). Data
from neuronal studies have suggested that increased
[Ca2+]m is associated with release of
cytochrome c from the mitochondria (28), an
early step in the apoptotic cascade (5). In the present study, use of the [Ca2+]m indicator
rhod 2 revealed that reperfused myocytes exhibited increased
[Ca2+]m compared with nonischemic
cells. However, the salient finding was that
[Ca2+]m in AN+ve cells was significantly
greater [Ca2+]m than AN
ve cells. Validation
of our [Ca2+]m measurements was made by
application of the uncoupler protonophore FCCP to normoxic cells,
loaded with either the [Ca2+]m indicator rhod
2 (in the presence of Mn2+ quenching) or the cytosolic free
Ca2+ indicator fluo 3. This protocol resulted in an
FCCP-induced decrease in [Ca2+]m and an
increase in cytosolic free Ca2+ (data not shown). Thus,
whereas increased [Ca2+]m has been implicated
in the initiation of apoptosis, to our knowledge, this is the
first report of elevated [Ca2+]m during
cardiomyocyte apoptosis.
Activation of executioner caspases, such as caspase 3, is a hallmark feature of apoptosis and is thought to be associated with irreversible morphological and nuclear damage (17, 26). Caspase-3-like activity appeared in cardiomyocytes after 20 min of SIsc and 60 min of SRP. However, the incidence of annexin V staining after 60 min of SRP was ~3-fold higher than the incidence of caspase-3-like activity. Furthermore, cells exhibiting caspase-3-like activity had a rounded morphology with membrane blebs. These findings are suggestive of an ongoing cardiomyocyte apoptotic program before caspase activation and loss of membrane integrity.
All of the characteristics that distinguished AN+ve myocytes from
AN
ve cells and necrotic cells in the present study support the
hypothesis that these cells are in the early stages of
apoptosis. Requirement of reperfusion for the apoptotic
program is well documented (6, 8, 21). Intracellular ATP
is critical for execution of apoptosis (5). The
presence of an intact cell membrane, cell shrinkage, and increased
[Ca2+]m is a hallmark characteristic of
apoptotic cells (5, 28). Induction of the
apoptotic program in cultured cardiomyocytes in response to
exogenous ROS has also been reported (15, 31). Given these
observations, the well-accepted use of annexin V as a reliable
indicator of ongoing apoptosis (27, 30) and the appearance of caspase-3-like activity during SRP, our results suggest
that in addition to necrosis, SRP after SIsc is accompanied by a
cardiomyocyte apoptosis program.
There were several limitations in the present study. First, the relatively short SRP times (20 and 60 min) most likely underestimated the true extent of cardiomyocyte apoptosis and necrosis. A second limitation pertains to the caspase detection assay, which may not be entirely specific for caspase-3 activity, and accordingly, we have chosen to use the terminology "caspase-3-like" activity. Furthermore, the true sensitivity of this assay for detection of caspase-3-like activity is unknown. Nevertheless, this assay has been used for detection of caspase-3-like activity in individual cardiomyocytes (30) and in other nonmyocyte studies (11, 36). Third, the use of an isolated cardiomyocyte model may have underestimated the true extent of injury compared with an in vivo preparation. However, use of an isolated myocyte preparation permits both mechanistic determinations and morphological characterization of cardiomyocyte injury. Fourth, the present study did not examine the mechanism for phosphatidylserine externalization during SRP. However, data from other cell types indicate that both oxidative stress and calcium overload can result in externalization of this phosphaminolipid (2, 16).
In conclusion, our findings indicate that annexin V staining detects a subpopulation of myocytes that exhibit characteristics similar to cells associated with apoptosis. The use of indicators of apoptosis, such as annexin V, enables identification of myocytes in the early stages of apoptosis, when they still retain rod-shaped morphology and contractile capacity. Early detection of apoptosis will not only facilitate mechanistic studies relating to this death program but may also aid in the development of therapeutic interventions that can potentially arrest this program.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Eric L. Kilpatrick and Dr. M. Salik Jahania for assistance in the completion of this study.
| |
FOOTNOTES |
|---|
This work was supported in part by the National Institutes of Health Grant HL-34579 (to R. M. Mentzer, Jr.) and a University of Kentucky Medical Center Research grant (to P. Narayan).
Address for reprint requests and other correspondence: P. Narayan, MN269, Dept. of Surgery, Univ. of Kentucky, 800 Rose St., Lexington, KY 40536 (E-mail: pnaraya{at}pop.uky.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 12 April 2001; accepted in final form 6 July 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Armstrong, SC,
Shivell LC,
and
Ganote CE.
Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes.
J Mol Cell Cardiol
33:
149-160,
2001[Web of Science][Medline].
2.
Bevers, EM,
Comfurius P,
Dekkers DW,
Harmsma M,
and
Zwaal RF.
Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance (Review).
Biol Chem
379:
973-986,
1998.
3.
Clodi, K,
Kliche KO,
Zhao S,
Weidner D,
Schenk T,
Consoli U,
Jiang S,
Snell V,
and
Andreeff M.
Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes.
Cytometry
40:
19-25,
2000[Web of Science][Medline].
4.
Delcamp, TJ,
Dales C,
Ralenkotter L,
Cole PS,
and
Hadley RW.
Intramitochondrial [Ca2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation.
Am J Physiol Heart Circ Physiol
275:
H484-H494,
1998
5.
Elsasser, A,
Suzuki K,
and
Schaper J.
Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure.
J Mol Cell Cardiol
32:
711-724,
2000[Web of Science][Medline].
6.
Fliss, H.
Accelerated apoptosis in reperfused myocardium: friend of foe?
Basic Res Cardiol
93:
90-93,
1998[Web of Science][Medline].
7.
Ganote, CE,
and
Armstrong SC.
Ischaemia and the myocyte cytoskeleton: review and speculation.
Cardiovasc Res
27:
1387-1403,
1993
8.
Gottlieb, RA,
Burleson KO,
Kloner RA,
Babior BM,
and
Engler RL.
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
J Clin Invest
94:
1621-1628,
1994.
9.
Haworth, RA,
Hunter DR,
and
Berkoff HA.
Contracture in isolated adult rat heart cells. Role of Ca2+, ATP, and compartmentation.
Circ Res
49:
1119-1128,
1981
10.
Henaff, M,
Hatem SN,
and
Mercadier JJ.
Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation.
Mol Pharmacol
58:
1546-1553,
2000
11.
Hirata, H,
Takahashi A,
Kobayashi S,
Yonehara S,
Sawai H,
Okasaki T,
Yamamoto K,
and
Sasada M.
Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis.
J Exp Med
187:
587-600,
1998
12.
Hohl, CM,
and
Altschuld RA.
Response of isolated adult canine cardiac myocytes to prolonged hypoxia and reoxygenation.
Am J Physiol Cell Physiol
260:
C383-C391,
1991
13.
Hreniuk, D,
Garay M,
Gaarde W,
Monia BP,
McKay RA,
and
Cioffi CL.
Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes.
Mol Pharmacol
59:
867-74,
2001
14.
Huh, J,
Gross GJ,
Nagase H,
and
Liang BT.
Protection of cardiac myocytes via
1-opioid receptors, protein kinase C, and mitochondrial KATP channels.
Am J Physiol Heart Circ Physiol
280:
H377-H383,
2001
15.
Inserte, J,
Taimor G,
Hofstaetter B,
Garcia-Dorado D,
and
Piper HM.
Influence of simulated ischemia on apoptosis induction by oxidative stress in adult cardiomyocytes of rats.
Am J Physiol Heart Circ Physiol
278:
H94-H99,
2000
16.
Kagan, VE,
Fabisiak JP,
Shvedova AA,
Tyurina YY,
Tyurin VA,
Schor NF,
and
Kawai K.
Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis (Review).
FEBS Lett
477:
1-7,
2000[Web of Science][Medline].
17.
Kang, PM,
Haunstetter A,
Aoki H,
Usheva A,
and
Izumo S.
Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation.
Circ Res
87:
118-125,
2000
18.
Kukreja, RC,
and
Janin Y.
Reperfusion injury: basic concepts and protection strategies.
J Thromb Thrombolysis
4:
7-24,
1997[Medline].
19.
Li, Q,
Hohl CM,
Altschuld RA,
and
Stokes BT.
Energy depletion-repletion and calcium transients in single cardiomyocytes.
Am J Physiol Cell Physiol
257:
C427-C434,
1989
20.
Martin, LJ.
Neuronal cell death in nervous system development, disease, and injury (Review).
Int J Mol Med
7:
455-478,
2001[Web of Science][Medline].
21.
Maulik, N,
Yoshida T,
and
Das DK.
Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis.
Free Radic Biol Med
24:
869-875,
1998[Web of Science][Medline].
22.
Miyamae, M,
Camacho SA,
Weiner MW,
and
Figueredo VM.
Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts.
Am J Physiol Heart Circ Physiol
271:
H2145-H2153,
1996
23.
Miyata, H,
Lakatta EG,
Stern MD,
and
Silverman HS.
Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia.
Circ Res
71:
605-613,
1992
24.
Narayan, P,
Mentzer RM, Jr,
and
Lasley RD.
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
J Mol Cell Cardiol
33:
121-129,
2001[Web of Science][Medline].
25.
Olivetti, G,
Quaini F,
Sala R,
Lagrasta C,
Corradi D,
Bonacina E,
Gambert SR,
Cigola E,
and
Anversa P.
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart.
J Mol Cell Cardiol
28:
2005-2016,
1996[Web of Science][Medline].
26.
Porter, AG,
and
Janicke RU.
Emerging roles of caspase-3 in apoptosis.
Cell Death Differ
6:
99-104,
1999[Web of Science][Medline].
27.
Rucker-Martin, C,
Henaff M,
Hatem SN,
Delpy E,
and
Mercadier JJ.
Early re-distribution of plasma membrane phosphatidylserine during apoptosis of adult rat ventricular myocytes in vitro.
Basic Res Cardiol
94:
171-179,
1999[Web of Science][Medline].
28.
Schild, L,
Keilhoff G,
Augustin W,
Reiser G,
and
Striggow F.
Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria.
FASEB J
15:
565-567,
2001
29.
Shen, HM,
Dong SY,
and
Ong CN.
Critical role of calcium overloading in cadmium-induced apoptosis in mouse thymocytes.
Toxicol Appl Pharmacol
171:
12-19,
2001[Web of Science][Medline].
30.
Suzuki, K,
Kostin S,
Person V,
Elsasser,
and
Schaper J.
Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes.
J Mol Cell Cardiol
33:
983-994,
2001[Web of Science][Medline].
31.
Taimor, G,
Hofstaetter B,
and
Piper HM.
Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia.
Cardiovasc Res
45:
588-594,
2000
32.
Toyoda, Y,
Di Gregorio V,
Parker RA,
Levitsky S,
and
McCully JD.
Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
Circulation
102:
III326-III331,
2000
33.
Van Engeland, M,
Nieland LJ,
Ramaekers FC,
Schutte B,
and
Reutelingsperger CP.
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.
Cytometry
31:
1-9,
1998[Web of Science][Medline].
34.
Veinot, JP,
Gattinger DA,
and
Fliss H.
Early apoptosis in human myocardial infarcts.
Hum Pathol
28:
485-492,
1997[Web of Science][Medline].
35.
Webster, KA,
Discher DJ,
Kaiser S,
Hernandez O,
Sato B,
and
Bishopric NH.
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.
J Clin Invest
104:
239-252,
1999[Web of Science][Medline].
36.
Zapata, JM,
Takahashi R,
Salvesen GS,
and
Reed JC.
Granzyme release and caspase activation in activated human T-lymphocytes.
J Biol Chem
273:
6916-6920,
1998
This article has been cited by other articles:
![]() |
D. Shan, R. B. Marchase, and J. C. Chatham Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes Am J Physiol Cell Physiol, March 1, 2008; 294(3): C833 - C841. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Tappia, M. S. Nijjar, A. Mahay, N. Aroutiounova, and N. S. Dhalla Phospholipid profile of developing heart of rats exposed to low-protein diet in pregnancy Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1400 - R1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Sun, N.-P. Wang, F. Kerendi, M. Halkos, H. Kin, R. A. Guyton, J. Vinten-Johansen, and Z.-Q. Zhao Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1900 - H1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cai, S. Ahmad, W. G. Jiang, J. Huang, C. D. Kontos, M. Boulton, and A. Ahmed Activation of Vascular Endothelial Growth Factor Receptor-1 Sustains Angiogenesis and Bcl-2 Expression Via the Phosphatidylinositol 3-Kinase Pathway in Endothelial Cells Diabetes, December 1, 2003; 52(12): 2959 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, I. Fantozzi, D. D. Tigno, E. S. Yi, O. Platoshyn, P. A. Thistlethwaite, J. M. Kriett, G. Yung, L. J. Rubin, and J. X.-J. Yuan Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L740 - L754. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A J Krijnen, R Nijmeijer, C J L M Meijer, C A Visser, C E Hack, and H W M Niessen Apoptosis in myocardial ischaemia and infarction J. Clin. Pathol., November 1, 2002; 55(11): 801 - 811. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |